|
![](https://webarchive.library.unt.edu/web/20090506033527im_/http://www.nida.nih.gov/images/spacer.gif)
NIDA Legislative Resources
- NIDA Legislative Chronology
- NIDA Directors Report - Complete
- Congressional Affairs Overview
- 2009: February
- 2008: February, May, September
- 2007: February, May, September
- 2006: February, May, September
- 2005: February, May, September
- 2004: February, May, September
- 2003: February, May, September
- 2002: February, May, September
- 2001: February, May, September
- 2000: February, May, September
- 1999: February, May, September
- 1998: February, May, September
- 1997: February, May, September
- 1996: February, May, September
- 1995: February, May, September
- Budget Information (Congressional Justification)
- Drug Abuse and Addiction Research - The Sixth Triennial Report to Congress
- Marijuana Research and Dissemination Update - March 2004 [PDF format - 248 Kb]
- Testimony to Congress
Index for 2009
Index for 2008
Index for 2007
Index for 2006
- Testimony at the United States Sentencing Commission Public Hearing on the scope, pharmacology and health consequences of cocaine abuse and addiction - Statement of Nora D. Volkow, M.D. (11/14/06)
- Efforts of the National Institute on Drug Abuse to Prevent and Treat Prescription Drug Abuse - Testimony Before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources Committee on Government Reform, United States House of Representatives - Statement of Nora D. Volkow, M.D. (7/26/06)
- Availability and Effectiveness of Programs to Treat Methamphetamine Abuse - Testimony before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources - Committee on Government Reform - United States House of Representatives - Statement of Nora D. Volkow, M.D. (6/28/06)
- Fiscal Year 2007 Budget Request - Testimony before the House Subcommittee on Labor-HHS-Education Appropriations - Statement of Nora D. Volkow, M.D. (3/16/06)
- An Examination of Drug Treatment Programs Needed to Ensure Successful Re-entry - Testimony before the Subcommittee on Crime, Terrorism, and Homeland Security, Committee on the Judiciary - Statement of Nora D. Volkow, M.D. (2/8/06)
Index for 2005
- Medications Development Research for Treatment of Amphetamine and Methamphetamine Addiction - Report to Congress (8/05)
- Substance Abuse and Mental Health Research and Services - Testimony before the House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies - Committee on Appropriations - Statement of Nora D. Volkow, M.D. (4/27/05)
- Methamphetamine Abuse - Testimony before the Senate Subcommittee on Labor, Health and Human Services, Education, and Related Agencies - Committee on Appropriations - Statement of Nora D. Volkow, M.D. (4/21/05)
- Fiscal Year 2006 Budget Request to Senate Subcommittee - Statement of Nora D. Volkow, M.D. (4/6/05)
- Fiscal Year 2006 Budget Request to House Subcommittee - Statement of Nora D. Volkow, M.D. (3/9/05)
- Consequences of the Abuse of Anabolic Steroids - Before the Committee on Government Reform - Statement of Nora D. Volkow, M.D. (3/17/05)
Index for 2004
Index for 2003
Index for 2002
- Research on MDMA - Testimony
Before the Subcommittee on Criminal Justice, Drug Policy and Human Resources - Statement of Glen R. Hanson, Ph.D., D.D.S. (9/19/02)
- Oversight Hearing on the Office of National Drug Control Policy's National Youth Anti-Drug Media Campaign - Statement of Wilson M. Compton, M.D, M.P.E. (6/20/02)
- Fiscal Year 2003 Budget Request - Statement of Glen R. Hanson, Ph.D., D.D.S. (3/13/02)
- "OxyContin: Balancing Risks and Benefits" - Hearing before the Health, Education, Labor, and Pensions Committee United States Senate (2/12/02)
Index for 2001
Index for 2000
Index for 1999
Index for 1998
Index for 1997
Other Legislative Links
Contact
National Institute on Drug Abuse
Office of Science Policy and Communications, Science Policy Branch
6001 Executive Boulevard, Room 5230, MSC 9591
Bethesda, Maryland 20892-9591
Phone : (301) 443-6071; Fax (301) 443-9731
e-mail: information@nida.nih.gov
|
|
|